Linda S. Wenger Joins Lung Cancer Foundation as Executive Director
Branding, marketing and public relations professional, Linda S. Wenger, has been named Executive Director of Uniting Against Lung Cancer, the nation’s largest non-profit funder of lung cancer research in North America—The announcement was made by the foundation’s president Mary Ann Tighe.
Ms. Wenger, who most recently directed the most successful fundraising, awareness and branding campaigns for National Jewish Fund during her seven-year tenure, will now lead the growing Uniting Against Lung Cancer into a new era of achievement in research funding.
As Executive Director, Ms. Wenger will work with the Board of Directors to execute the foundation’s development and national growth initiatives. She will also work with Uniting’s Scientific Program Director and 10-member Medical Committee to keep the foundation’s constituents abreast of lung cancer research developments and foster greater communication between the nation’s leading research minds and laboratories. Ms. Wenger will create and implement marketing and public relations strategies, to increase funding and visibility for the organization. Additionally, she will work with like-minded organizations and families across America to provide them the information, support and access to research that will enable them to join the fight against lung cancer.
Prior to joining Uniting Against Lung Cancer, Ms. Wenger served as Executive Director, Marketing and Communications for the Jewish National Fund in New York City. There she built an integrated marketing team, developed an award-winning website and significantly increased online business, among other accomplishments. Previously she was the Vice President of Development for several advertising and PR firms, including Geer, DuBois and Gilbert, Whitney & Johns. Past clients include IBM, American Express, Panasonic, Barnes & Noble and Time Warner.
Ms. Wenger has credits toward a MBA in Marketing Management from Bernard Baruch College, CUNY in New York City and a BA from the University of Virginia.
Uniting Against Lung Cancer has funded $12 million in research in the last eight years. Originally named Joan’s Legacy, the foundation became Uniting in 2009 to reflect its merger with the Thomas G. Labrecque Foundation, and its unifying role as a lightening rod in funding the most innovative lung cancer research. Uniting is now the largest private non-profit funder of lung cancer research in North America, recognized as “the venture capital” in this unique arena.